Improvement of glucose levels into the normal range can occur in some people living with
diabetes, either spontaneously or after medical interventions, and in some cases can persist …

Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and
elevated blood glucose levels. Although a large drug portfolio exists to keep the blood …

Cardiovascular disease risk factor control as primary prevention in patients with type 2
diabetes mellitus has changed substantially in the past few years. The purpose of this …

Background Glycated hemoglobin (HbA1c) is used to diagnose type 2 diabetes (T2D) and
assess glycemic control in patients with diabetes. Previous genome-wide association …

Despite US Food and Drug Administration (FDA) approval of over 40 new treatment options
for type 2 diabetes since 2005, the latest data from the National Health and Nutrition …

Background: Type 2 diabetes is associated with dementia risk, but evidence is limited for
possible associations of diabetes and prediabetes with cognitive decline. Objective: To …

Objective To assess the effect of targeting intensive glycaemic control versus conventional
glycaemic control on all cause mortality and cardiovascular mortality, non-fatal myocardial …

Objective: The aim was to provide a scholarly review of the published literature on
biological, clinical, and nonclinical contributors to race/ethnic and sex disparities in …

Background Treatment guidelines for prediabetes primarily focus on glycemic control and
lifestyle management. Few evidence-based cardiovascular and kidney risk-reduction …

Objective The molecular pathogenesis of late complications associated with type 2 diabetes
mellitus (T2DM) is not yet fully understood. While high glucose levels indicated by increased …